# OnCo record paper-cartbcma-hcb-01-lancet-oncol-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-cartbcma-hcb-01-lancet-oncol-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-cartbcma-hcb-01-lancet-oncol-2023" ;
  schema:name "Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study"@en ;
  schema:description "The interim results of Hospital Clínic's academic BCMA CAR-T for myeloma: every one of 30 treated patients responded in the first 100 days, with no neurotoxic events."@en ;
  schema:url <https://onco.cc/key-papers/paper-cartbcma-hcb-01-lancet-oncol-2023/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(23)00222-X>, <https://pubmed.ncbi.nlm.nih.gov/37414060/> ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(23)00222-X> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Oliver-Caldés A, González-Calle V, Cabañas V, et al." ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:technologies <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/point-of-care-cell-manufacturing/> ;
  onco:targets <https://onco.cc/targets/bcma/> ;
  onco:institutions <https://onco.cc/institutions/hospital-clinic-barcelona/>, <https://onco.cc/institutions/isciii/> ;
  onco:trials <https://onco.cc/trials/cartbcma-hcb-01/> ;
  onco:people <https://onco.cc/people/julio-delgado/>, <https://onco.cc/people/manel-juan/>, <https://onco.cc/people/maria-victoria-mateos/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .